<html>
<head>PUBMED IDs for BEX1</head>
<body bgcolor='#C5F0F2'><h1>BEX1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11989783/'>Cloning and expression pattern of a spermatogenesis-related gene, BEX1, mapped to chromosome Xq22.</a> May 7  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/15920485/'>Expression of BEX1 in acute myeloid leukemia with MLL rearrangements.</a> May 28  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16818640/'>Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma.</a> July 5  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17638883/'>BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines.</a> July 20  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18827820/'>Identification of novel neuroendocrine-specific tumour genes.</a> October 2  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21853033/'>Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.</a> December 20  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23203637/'>SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer.</a> May 29  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23362108/'>Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma.</a> August 28  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24626299/'>BEX1 promotes imatinib-induced apoptosis by binding to and antagonizing BCL-2.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26046670/'>BEX1 acts as a tumor suppressor in acute myeloid leukemia.</a> June 11  2015<br></body></html>
